Delivery Order SPE2DB20D3101-SPE2DB25FRRK7
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,171.20 to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 micrograms nasal spray (16 grams) on August 28, 2025, with completion scheduled for August 29, 2025. This is a firm fixed price contract with no set-aside designation, indicating it was competitively awarded. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is located. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order valued at $2,447.32 to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 micrograms nasal spray (16 grams) on August 21, 2025, with completion scheduled for August 22, 2025. This non-set-aside contract was competitively awarded using firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger contract vehicle. The pharmaceutical product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $2,596.32 to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 micrograms nasal spray (16 grams) on September 9, 2025, with completion scheduled for September 10, 2025. The contract utilizes firm fixed-price pricing with no set-aside designation, indicating it was competitively awarded. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical supply...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,606.19 on August 15, 2025, for Fluticasone Propionate 50 microgram nasal spray in 16-gram units. The contract carries a firm fixed price structure with no set-aside designation, indicating it was competitively awarded. Performance will be completed by August 18, 2025, with the product to be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,175.93 delivery order on September 15, 2025, for Fluticasone Propionate 50 microgram nasal spray (16 grams). This is a firm fixed-price, non-set-aside contract with a completion date of September 16, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp supplies a...
- The Defense Logistics Agency awarded a delivery order valued at $1,660.38 to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 microgram nasal spray (16-gram units) on September 17, 2025, with completion scheduled for September 18, 2025. This competitive award uses firm fixed pricing with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,370.42 to AmerisourceBergen Drug Corp on September 10, 2025, for Fluticasone Propionate 50 microgram nasal spray (16 grams). This is a firm fixed price delivery order with no set-aside designation, competitively awarded through open competition. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 11, 2025. As a child order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Fluticasone Propionate 50 micrograms nasal spray in 16-gram units, with a ceiling value of $1,716.74. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The work is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,171.20 to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 microgram nasal spray in 16-gram quantities. This firm fixed-price delivery order, awarded on July 29, 2025, with ultimate completion by July 30, 2025, represents a direct purchase of pharmaceutical products for federal medical supply needs. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen, headquartered in...
- The Defense Logistics Agency awarded a $2,369.39 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 micrograms nasal spray (16 grams), with an ultimate completion date of August 11, 2025. This non-set-aside contract was competitively awarded on August 8, 2025, with performance to be executed from the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRRK7Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,008.40 to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 microgram nasal spray (16 grams) on July 30, 2025, with completion targeted for July 31, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026, which serves as the primary vehicle for pharmaceutical procurement supporting military healthcare systems globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving critical federal medical procurement needs, particularly for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio of federal contracts demonstrates its capability to fulfill diverse pharmaceutical requirements, ranging from brand-name and generic medications to vaccines and specialized medical supplies across multiple therapeutic domains. The underlying indefinite delivery contract represents a comprehensive global pharmaceutical support vehicle enabling the contractor to supply products supporting military healthcare programs worldwide, reflecting the strategic importance of reliable pharmaceutical distribution to the Department of Defense supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 7/30/25 |